E-LIB Suche - Ergebnisse für: Fernandez‐Teruel, Carlos

1

Application of population physiologically based pharmacokin..:

Reig‐Lopez, Javier ; Tang, Weifeng ; Fernandez‐Teruel, Carlos...
British Journal of Clinical Pharmacology. 89 (2023) 9 - p. 2691-2702 , 2023

Link: https://doi.org/10.1111/..

2

Population Pharmacokinetic‐Pharmacodynamic Modeling and Cov..:

Fernández‐Teruel, Carlos ; Lubomirov, Rubin ; Fudio, Salvador
The Journal of Clinical Pharmacology. 61 (2021) 9 - p. 1206-1219 , 2021

Link: https://doi.org/10.1002/..

3

Phase I/II study of weekly PM00104 (Zalypsis®) in patients ..:

Ocio, Enrique M. ; Oriol, Albert ; Bladé, Joan...
British Journal of Haematology. 172 (2015) 4 - p. 625-628 , 2015

Link: https://doi.org/10.1111/..

4

A new mathematical approach for the estimation of the AUC a..:

Navarro‐Fontestad, Carmen ; González‐Álvarez, Isabel ; Fernández‐Teruel, Carlos..
Pharmaceutical Statistics. 11 (2011) 1 - p. 14-23 , 2011

Link: https://doi.org/10.1002/..

5

In situ kinetic modelling of intestinal efflux in rats: fun..:

González‐Alvarez, Isabel ; Fernández‐Teruel, Carlos ; Casabó‐Alós, Vicente G....
Biopharmaceutics & Drug Disposition. 28 (2007) 5 - p. 229-239 , 2007

Link: https://doi.org/10.1002/..

6

Quantitative determination of lurbinectedin, its unbound fr..:

King, Nicholas ; Garcia-Martinez, Soledad ; Alcaraz, Eider...
PLOS ONE. 18 (2023) 3 - p. e0283783 , 2023

Link: https://doi.org/10.1371/..

7

Phase I study of lurbinectedin in combination with weekly p..:

Calvo, Emiliano ; Sessa, Cristiana ; Harada, Guilherme...
Investigational New Drugs. 40 (2022) 6 - p. 1263-1273 , 2022

Link: https://doi.org/10.1007/..

8

Integrated exposure–response analysis of efficacy and safet..:

Fernández-Teruel, Carlos ; Fudio, Salvador ; Lubomirov, Rubin
Cancer Chemotherapy and Pharmacology. 89 (2021) 5 - p. 585-594 , 2021

Link: https://doi.org/10.1007/..

9

Effect of lurbinectedin on the QTc interval in patients wit..:

Fudio, Salvador ; Tabernero, Josep ; Subbiah, Vivek...
Cancer Chemotherapy and Pharmacology. 87 (2020) 1 - p. 113-124 , 2020

Link: https://doi.org/10.1007/..

10

Population-Pharmacokinetic and Covariate Analysis of Lurbin..:

Fernandez-Teruel, Carlos ; Gonzalez, Ignacio ; Trocóniz, Iñaki F....
Clinical Pharmacokinetics. 58 (2018) 3 - p. 363-374 , 2018

Link: https://doi.org/10.1007/..

11

Phase I study of carboplatin in combination with PM00104 (Z..:

Salazar, Ramón ; Calles, Antonio ; Gil, Marta...
Investigational New Drugs. 32 (2014) 4 - p. 644-652 , 2014

Link: https://doi.org/10.1007/..

12

Phase II clinical trial of PM00104 (Zalypsis®) in urothelia..:

Castellano, Daniel E. ; Bellmunt, Joaquim ; Maroto, José Pablo...
Cancer Chemotherapy and Pharmacology. 73 (2014) 4 - p. 857-867 , 2014

Link: https://doi.org/10.1007/..

13

Erratum to: Phase I study of PM00104 (Zalypsis®) administer..:

Massard, Christophe ; Margetts, Jane ; Amellal, Nadia...
Investigational New Drugs. 31 (2013) 3 - p. 799-799 , 2013

Link: https://doi.org/10.1007/..

14

Phase I clinical and pharmacokinetic study of trabectedin a..:

Sessa, Cristiana ; Del Conte, Gianluca ; Christinat, Alexandre...
Investigational New Drugs. 31 (2013) 5 - p. 1236-1243 , 2013

Link: https://doi.org/10.1007/..

15

A comprehensive safety analysis confirms rhabdomyolysis as ..:

Grosso, Federica ; D'Incalci, Maurizio ; Cartoafa, Mirela...
Cancer Chemotherapy and Pharmacology. 69 (2012) 6 - p. 1557-1565 , 2012

Link: https://doi.org/10.1007/..